In 2023, we continued to commit to building families and helping people live better lives by launching two first-in-class medicines, marking the start of an exciting phase of growth.
Read our 2023 #AnnualReport: bit.ly/4cRIRCb
Read our 2023 #AnnualReport: bit.ly/4cRIRCb
0:55